Top Markets
#1 Prom Prom +32.17%
#2 QuantixAI QuantixAI +31.15%
#3 Velvet Velvet +29.00%
#4 MowCat MowCat +28.71%
#5 Tutorial Tutorial +25.72%
#6 UnifAI Network UnifAI Network +23.74%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.78%
#8 MarsCoin MarsCoin +18.77%
#9 Versatize Coin Versatize Coin +16.65%
#10 Kinesis Silver Kinesis Silver +14.47%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
TuHURA Biosciences, Inc. TuHURA Biosciences, Inc.

TuHURA Biosciences, Inc.

HURA
Rank in Stocks #20518
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the... TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Share Price
$2.02
Last synced: 2026-08-21
Market Cap
$128.32M
Change (1 day)
-9.23%
Change (1 year)
-38.00%
Country
US
Trade TuHURA Biosciences, Inc. (HURA)

Category

Healthcare
Revenue for TuHURA Biosciences, Inc. (HURA)
Revenue in Aug 2026 TTM: 0
According to TuHURA Biosciences, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for TuHURA Biosciences, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH